Zacks.com on MSN4h
ABBV's Acquisition Spree Continues: Buy, Sell or Hold the Stock?AbbVie ABBV continued its acquisition spree with the announcement of a definitive agreement to acquire private biotech Nimble ...
Even as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla slowly roll out onto the market, experts question the efficacy of ...
Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here, BioSpace looks at five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback